Focus Taiwan
Date: 2019/02/27
By: Chang Ming-hsuan and Elizabeth Hsu
Taipei, Feb. 27 (CNA) The Taiwan Food and Drug Administration (FDA) said Wednesday that it has issued
Photo courtesy of the Taiwan Food and Drug Administration (FDA)
a recall order for three blood pressure-lowering drugs, namely Exnortan, Daianxo, and Co-Daianxo, which were found to contain trace amounts of a carcinogen.
The immediate recall follows similar action over the past few months by the FDA after it was revealed that one of the key ingredients in blood pressure drugs produced in India and China was tainted with the carcinogen N-nitrosodimethylamine (NDMA).
The latest information came from two pharmaceutical firms, which said they had found NDMA in the ingredients used to make the blood pressure drugs Exnortan film coated tablets (5/80 milligram), Daianxo film coated tablets (160mg) and Co-Daianxo capsules (80/12.5mg), FDA deputy division chief Wu Ming-mei (吳明美) said at a press conference.
Some 6 million tablets have already been shipped, Wu said, adding that there is no telling how many are on the Taiwan market. [FULL STORY]
